Arterium launches new dosage of Inspiron

Arterium Corporation has added a new dosage of Inspiron to its product portfolio—the drug is now available as a syrup 4 mg/ml.
The new presentation with a larger active agent dose will make the drug much easier for patients to use. Inspiron syrup 4 mg/ml is suitable for older children and adults since it can be consumed in smaller quantities (just 1.5-3 tablespoons/day instead of 3-6 tablespoons).
The new dosage will enhance the existing line-up of Inspiron drugs, which includes tablets and syrup 2 mg/ml already. Inspiron is used in treatment of acute and chronic diseases of ENT organs and the lower respiratory tract; as a part of combined therapy for bronchial asthma, seasonal and perennial allergic rhinitis and other allergic manifestations on the part of the respiratory system and ENT organs, respiratory manifestations of measles, influenza; and symptomatic treatment for pertussis.
The information is provided for medical and pharmaceutical personnel only and shall be used exclusively in relevant professional activities. The information given here is abridged. For full information about Inspiron tablets, Inspiron syrup 2 mg/ml and Inspiron syrup 4 mg/ml, refer to the instructions for their medical use.
This website is a specialised publication intended for medical and pharmaceutical personnel only.